May 21, 2024

Dermatology CRO Market Size To Cross USD 8.7 Bn By 2030

The global dermatology CRO market size accounted for US$ 5.11  Bn in 2022 and is projected to reach around USD 8.7Bn by 2030, growing at a CAGR of 6.88% from 2022 to 2030.

Dermatology CRO Market Size 2022 To 2030

Report Summary

The global dermatology CRO market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the dermatology CRO market across the globe.

A comprehensive estimate on the dermatology CRO market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of dermatology CRO during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2403

Dermatology CRO Market Report Scope 

Report CoverageDetails
Market Size in 2022USD 5.11 Billion
Market Size by 2030USD 8.7 Billion
Growth Rate from 2022 to 2030CAGR of 6.88%
Base Year2021
Forecast Period2022 to 2030
Segments Covered
  • By Service
  • By Type
  • By Phase Type

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized dermatology CRO market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read:  Melt Electrowriting Technology Market Size Analysis 2022 To 2030

Dermatology CRO Market  Players

The report includes the profiles of key dermatology CRO market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • IQVIA HOLDINGS INC.
  • Covance Inc.
  • Pharmaceutical Product Development, LLC (PPD)
  • Parexel International Corporation
  • Charles River Laboratories International, Inc.
  • Icon, Plc
  • Medidata Solutions, Inc.
  • Syneos Health
  • Pharmaron
  • GVK Biosciences Private Limited
  • Wuxi AppTec
  • MEDPACE HOLDINGS, INC.
  • PRA Health Sciences
  • CTI Clinical Trial & Consulting
  • Bioskin
  • Proinnovera
  • Biorasi
  • Javara
  • TFS

Market Segmentation

By Service

  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/Assurance
  • Bio-statistics
  • Investigator Payments
  • Laboratory
  • Patient and Site Recruitment
  • Technology
  • Others

By Type

  • Drug Discovery
    • Target Validation
    • Lead Identification
    • Lead optimization
  • Preclinical
  • Clinical

By Phase Type

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Dermatology CRO Market 

5.1. COVID-19 Landscape: Dermatology CRO Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Dermatology CRO Market, By Service

8.1. Dermatology CRO Market, by Service, 2022-2030

8.1.1 Project Management/Clinical Supply Management

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Data Management

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Regulatory/Medical Affairs

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Regulatory/Medical Affairs

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Clinical Monitoring

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Quality Management/Assurance

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Bio-statistics

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Investigator Payments

8.1.8.1. Market Revenue and Forecast (2017-2030)

8.1.9. Laboratory

8.1.9.1. Market Revenue and Forecast (2017-2030)

8.1.10. Clinical Monitoring

8.1.10.1. Market Revenue and Forecast (2017-2030)

8.1.11. Technology

8.1.11.1. Market Revenue and Forecast (2017-2030)

8.1.12. Clinical Monitoring

8.1.12.1. Market Revenue and Forecast (2017-2030)

8.1.13. Others

8.1.13.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Dermatology CRO Market, By Type

9.1. Dermatology CRO Market, by Type, 2022-2030

9.1.1. Drug Discovery

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Preclinical

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Clinical

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Dermatology CRO Market, By Phase Type 

10.1. Dermatology CRO Market, by Phase Type, 2022-2030

10.1.1. Phase I

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Phase II

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Phase III

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Phase IV

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Dermatology CRO Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Service (2017-2030)

11.1.2. Market Revenue and Forecast, by Type (2017-2030)

11.1.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Service (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Type (2017-2030)

11.1.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Service (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Type (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Service (2017-2030)

11.2.2. Market Revenue and Forecast, by Type (2017-2030)

11.2.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Service (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Type (2017-2030)

11.2.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Service (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Type (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Service (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Type (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Service (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Type (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Service (2017-2030)

11.3.2. Market Revenue and Forecast, by Type (2017-2030)

11.3.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Service (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Type (2017-2030)

11.3.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Service (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Type (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Service (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Type (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Service (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Type (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Service (2017-2030)

11.4.2. Market Revenue and Forecast, by Type (2017-2030)

11.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Service (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Type (2017-2030)

11.4.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Service (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Type (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Service (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Type (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Service (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Type (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Service (2017-2030)

11.5.2. Market Revenue and Forecast, by Type (2017-2030)

11.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Service (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Type (2017-2030)

11.5.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Service (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Type (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)

Chapter 12. Company Profiles

12.1. IQVIA HOLDINGS INC.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Covance Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Pharmaceutical Product Development, LLC (PPD)

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Parexel International Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Charles River Laboratories International, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Icon, Plc

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Medidata Solutions, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Syneos Health

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Pharmaron

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. GVK Biosciences Private Limited

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com